Effect of Acarbose and Mixture of Pioglitazone and Metformin in Patients With Type 2 Diabetes
Conditions: Type 2 Diabetes; Blood Glucose Fluctuation Interventions: Drug: Metformin plus pioglitazone; Drug: Acarbose Sponsor: Nanjing First Hospital, Nanjing Medical University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Acarbose | Actos | Diabetes | Diabetes Type 2 | Endocrinology | Fortamet | Hospitals | Metformin | Research